Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Clinical trial NCT03311503 · RECRUITING

Trial details

NCT number: NCT03311503
Sponsor: David Williams
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Severe Combined Immunodeficiency, X Linked Gene Therapy

Start date: 2018-02-26
Primary completion: 2028-01-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.